GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » PuriBlood Medical Co Ltd (ROCO:6847) » Definitions » EV-to-FCF

PuriBlood Medical Co (ROCO:6847) EV-to-FCF : 163.61 (As of Dec. 15, 2024)


View and export this data going back to 2021. Start your Free Trial

What is PuriBlood Medical Co EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, PuriBlood Medical Co's Enterprise Value is NT$1,446.5 Mil. PuriBlood Medical Co's Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2024 was NT$8.8 Mil. Therefore, PuriBlood Medical Co's EV-to-FCF for today is 163.61.

The historical rank and industry rank for PuriBlood Medical Co's EV-to-FCF or its related term are showing as below:

ROCO:6847' s EV-to-FCF Range Over the Past 10 Years
Min: -78.72   Med: -31.26   Max: 170.86
Current: 170.86

During the past 6 years, the highest EV-to-FCF of PuriBlood Medical Co was 170.86. The lowest was -78.72. And the median was -31.26.

ROCO:6847's EV-to-FCF is ranked worse than
93.88% of 98 companies
in the Medical Diagnostics & Research industry
Industry Median: 27.3 vs ROCO:6847: 170.86

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2024-12-15), PuriBlood Medical Co's stock price is NT$105.00. PuriBlood Medical Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2024 was NT$-3.220. Therefore, PuriBlood Medical Co's PE Ratio (TTM) for today is At Loss.


PuriBlood Medical Co EV-to-FCF Historical Data

The historical data trend for PuriBlood Medical Co's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PuriBlood Medical Co EV-to-FCF Chart

PuriBlood Medical Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-FCF
Get a 7-Day Free Trial - - -46.06 -44.56 75.63

PuriBlood Medical Co Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only - -44.56 - 75.63 -

Competitive Comparison of PuriBlood Medical Co's EV-to-FCF

For the Diagnostics & Research subindustry, PuriBlood Medical Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PuriBlood Medical Co's EV-to-FCF Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, PuriBlood Medical Co's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where PuriBlood Medical Co's EV-to-FCF falls into.



PuriBlood Medical Co EV-to-FCF Calculation

PuriBlood Medical Co's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=1446.519/8.841
=163.61

PuriBlood Medical Co's current Enterprise Value is NT$1,446.5 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. PuriBlood Medical Co's Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2024 was NT$8.8 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


PuriBlood Medical Co  (ROCO:6847) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

PuriBlood Medical Co's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=105.00/-3.220
=At Loss

PuriBlood Medical Co's share price for today is NT$105.00.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. PuriBlood Medical Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2024 was NT$-3.220.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


PuriBlood Medical Co EV-to-FCF Related Terms

Thank you for viewing the detailed overview of PuriBlood Medical Co's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


PuriBlood Medical Co Business Description

Traded in Other Exchanges
N/A
Address
Gongye E. 9th Road, Baoshan Township, 2nd Floor, No.11, Hsinchu County, Baoshan, TWN
PuriBlood Medical Co Ltd is engaged in developing solutions for leukoreduction, cell separation, and anti-fouling materials. Its technology provides protection to support living beings from medical devices to daily protection. The products of the company include Leukoreduction, Cell Seperation, and P-tex.

PuriBlood Medical Co Headlines

No Headlines